EXTL2 Antikörper (AA 5-110) (Biotin)

Produktnummer ABIN761053

Produktdetails anti-EXTL2 Antikörper (Biotin)

Target: EXTL2 (Exostoses (Multiple)-Like 2 (EXTL2))

Bindungsspezifität: AA 5-110

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser EXTL2 Antikörper ist konjugiert mit Biotin

Applikation: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Homologie: Human,Mouse,Rat,Dog,Sheep,Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human EXTL

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu EXTL2

Target: EXTL2 (Exostoses (Multiple)-Like 2 (EXTL2))

Andere Bezeichnung: EXTL2 (EXTL2 Produkte)

Synonyme: 3000001D04Rik antikoerper, AW146439 antikoerper, EXTR2 antikoerper, exostoses (multiple)-like 2 antikoerper, exostosin like glycosyltransferase 2 antikoerper, exostosin-like glycosyltransferase 2 antikoerper, Extl2 antikoerper, EXTL2 antikoerper

Hintergrund:

Synonyms: Alpha 1 4 N acetylhexosaminyltransferase EXTL2, Alpha GalNAcT EXTL2, Exostoses multiple like 2, Exostoses multiple like 2, Exostosin like 2, EXT L2, EXT related protein 2, EXTL 2, EXTR 2, EXTR2, Glucuronyl galactosyl proteoglycan 4 alpha N acetylglucosaminyltransferase, Multiple exostoses like 2, Processed exostosin like 2, EXTL2_HUMAN.

Background: EXTL2 is a glycosyltransferase required for the biosynthesis of heparan-sulfate and is responsible for the alternating addition of beta-1-4-linked glucuronic acid (GlcA) and alpha-1-4-linked N-acetylglucosamine (GlcNAc) units to nascent heparan sulfate chains.

Gen-ID: 2134